Irbesartan in patients with atrial fibrillation

S Yusuf, JS Healey, J Pogue, S Chrolavicius, M Flather, RG Hart, SH Hohnloser, CD Joyner, MA Pfeffer, SJ Connolly

Research output: Contribution to journalArticle

173 Citations (Scopus)

Abstract

Irbesartan did not reduce cardiovascular events in patients with atrial fibrillation. (Funded by Bristol-Myers Squibb and Sanofi-Aventis; ClinicalTrials.gov number, NCT00249795.).
Original languageEnglish
Pages (from-to)928-938
Number of pages11
JournalNew England Journal of Medicine
Volume364
Issue number10
DOIs
Publication statusPublished - 2011

Cite this